NCT07204756 HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
| NCT ID | NCT07204756 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Postpartum |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2026-01-07 |
| Primary Completion | 2028-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2026-01-07 with a primary completion date of 2028-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * Discharged after delivery at University of Minnesota Medical Center * Enrolled into the HOPE-BP Program Exclusion Criteria: * Ongoing antihypertensive medication use at 2 weeks (time of randomization) * Have a medical comorbidity that would not be clinically appropriate to randomize * Patients opted out of clinical research
Contact & Investigator
Bethany Sabol, MD MAS
PRINCIPAL INVESTIGATOR
University of Minnesota
Frequently Asked Questions
Who can join the NCT07204756 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Postpartum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07204756 currently recruiting?
Yes, NCT07204756 is actively recruiting participants. Contact the research team at linde491@umn.edu for enrollment information.
Where is the NCT07204756 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT07204756 clinical trial?
NCT07204756 is sponsored by University of Minnesota. The principal investigator is Bethany Sabol, MD MAS at University of Minnesota. The trial plans to enroll 400 participants.